Free Newsletter

FEATURES >> 15 Top Blockbuster Contenders | 10 Promising Therapeutic Vaccines

SPOTLIGHT: Breast cancer therapies get nod

September 14, 2007 — 5:59am ET

ALSO NOTED: FDA nixes Avastin for breast cancer; P&G reveals Phase II UC data;and much more...
Avastin re-submitted to FDA
FDA approves Avastin for lung cancer
SPOTLIGHT: FDA expands Avastin label
ALSO NOTED: Lilly grabs rights to pain therapy; Study outlines billions in potential R&D savings; Takeda shares hit by FDA move

Tools

Subscribe
Email
Print
Contact Author
Reprint

Breast cancer is making headlines today: Eli Lilly got the FDA's nod to market its osteoporosis drug Evista as a breast cancer preventative, and Genentech got word that the agency will consider its colon-and-lung cancer drug Avastin for breast cancer treatment. FiercePharma

SHARE
WITH: